## **Core Concept**
The question targets the pharmacological management of leprosy, specifically focusing on bactericidal drugs against *Mycobacterium leprae*. Leprosy, also known as Hansen's disease, requires multidrug therapy (MDT) that includes bactericidal agents to effectively target the causative bacterium.

## **Why the Correct Answer is Right**
The correct answer, , is known for its bactericidal activity against *Mycobacterium leprae*. Rifampicin works by inhibiting RNA synthesis in bacteria, making it highly effective against *M. leprae*. It is a key component of the multidrug therapy regimen recommended by the World Health Organization for the treatment of leprosy.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is not primarily bactericidal against *M. leprae*; it is more commonly associated with the treatment of tuberculosis and certain types of bacterial infections, not leprosy.
* **Option B:** is used in the treatment of leprosy but is primarily bacteriostatic against *M. leprae*, not bactericidal.
* **Option D:** is not typically used as a first-line treatment for leprosy and lacks significant bactericidal activity against *M. leprae*.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that the multidrug therapy (MDT) for leprosy, as recommended by the World Health Organization, includes rifampicin (a bactericidal agent) along with dapsone and clofazimine. This combination is critical for effectively treating leprosy and preventing resistance.

## **Correct Answer:** .